Patent application number | Description | Published |
20130294356 | CHANNEL ACCESS SYSTEMS AND METHODS FOR COGNITIVE RELAYING FOR CELLULAR SYSTEMS - Embodiments contemplate channel access systems and methods for cognitive relaying in unlicensed and lightly licensed bands. Embodiments contemplate managing nodes of a wireless network operating in an unlicensed and or lightly licensed band. One or more embodiments may include sensing an idle channel in the unlicensed and/or lightly licensed band. Further, embodiments contemplate using the idle channel for wireless communication. | 11-07-2013 |
20140355507 | ADJUSTING PRIORITY OF MBMS AND FEMTO CELLS - A UE may camp on a femto cell in an idle mode and determine whether the UE has an interest in receiving an MBMS service from an MBMS cell. When the UE has the interest in receiving the MBMS service, the UE adjusts a priority of the MBMS cell on which the MBMS service is provided or a priority of the femto cell such that the priority of the MBMS cell is higher than the priority of the femto cell. Otherwise, the UE refrains from adjusting the priority of the MBMS cell or the priority of the femto cell. | 12-04-2014 |
20150056997 | METHODS AND APPARATUS FOR IMPROVED CELL RE-SELECTION WITH AUTONOMOUS SEARCH FUNCTION - Apparatus and methods are described for identifying candidate cells on at least one frequency, where each of the candidate cells is associated with a cell quality, storing information related to each of the candidate cells in a candidate list, sorting the candidate list, and decoding a master information block (MIB) and one or more system information blocks (SIBs) for a subset of the candidate cells based on the sorting. | 02-26-2015 |
20150079988 | INTER-RAT AND INTRA-RAT SMALL CELL RESELECTION - Cell reselection for transitioning a user device from a macro cell to a small cell may be performed by comparing a first reselection candidate small cell and a second reselection candidate small cell based on reselection criteria, and selecting a final reselection candidate based on the comparison. | 03-19-2015 |
Patent application number | Description | Published |
20080306053 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH - The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands. | 12-11-2008 |
20080306093 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH - The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands. | 12-11-2008 |
20110224155 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH - The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands. | 09-15-2011 |
20110230502 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH - The present invention provides screening methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors as well as modifiers capable of modulating chemosensory receptors and their ligands. | 09-22-2011 |
20140235623 | MODULATION OF CHEMOSENSORY RECEPTORS AND LIGANDS ASSOCIATED THEREWITH - The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands. | 08-21-2014 |
Patent application number | Description | Published |
20110264447 | SYSTEMS, METHODS, AND APPARATUS FOR SPEECH FEATURE DETECTION - Implementations and applications are disclosed for detection of a transition in a voice activity state of an audio signal, based on a change in energy that is consistent in time across a range of frequencies of the signal. | 10-27-2011 |
20110288860 | SYSTEMS, METHODS, APPARATUS, AND COMPUTER-READABLE MEDIA FOR PROCESSING OF SPEECH SIGNALS USING HEAD-MOUNTED MICROPHONE PAIR - A noise cancelling headset for voice communications contains a microphone at each of the user's ears and a voice microphone. The headset shares the use of the ear microphones for improving signal-to-noise ratio on both the transmit path and the receive path. | 11-24-2011 |
20120020485 | SYSTEMS, METHODS, APPARATUS, AND COMPUTER-READABLE MEDIA FOR MULTI-MICROPHONE LOCATION-SELECTIVE PROCESSING - A multi-microphone system performs location-selective processing of an acoustic signal, wherein source location is indicated by directions of arrival relative to microphone pairs at opposite sides of a midsagittal plane of a user's head. | 01-26-2012 |
20120128160 | THREE-DIMENSIONAL SOUND CAPTURING AND REPRODUCING WITH MULTI-MICROPHONES - Systems, methods, apparatus, and machine-readable media for three-dimensional sound recording and reproduction using a multi-microphone setup are described. | 05-24-2012 |
20120128175 | SYSTEMS, METHODS, APPARATUS, AND COMPUTER-READABLE MEDIA FOR ORIENTATION-SENSITIVE RECORDING CONTROL - Systems, methods, apparatus, and machine-readable media for orientation-sensitive selection and/or preservation of a recording direction using a multi-microphone setup are described. | 05-24-2012 |
20140341380 | AUTOMATED GAIN MATCHING FOR MULTIPLE MICROPHONES - A method includes receiving, at a processor, a first data frame at a first time from a first microphone. The method also includes receiving a second data frame at the first time from a second microphone. The method further includes calculating a power ratio of the first microphone and the second microphone based on the first data frame and the second data frame in response to determining that the first data frame and the second data frame are noise data frames. | 11-20-2014 |
Patent application number | Description | Published |
20110162883 | CABLE ORGANIZATION ASSEMBLIES - Cable organization assemblies and methods of making said assemblies are provided herein. Preferred assemblies are directed to releasably coupling two or more audio wires to prevent entanglement. Headphones having two audio cables configured to zip together to prevent entanglement and subsequently zip apart are provided herein. | 07-07-2011 |
20120045084 | CABLE ORGANIZATION ASSEMBLIES - Cable assemblies comprising at least a first wire and a second wire are provided. The wires are enclosed, using injection molding, by a respective layer of thermo-resistant material. During the injection molding, the first wire and second wire are kept substantially straight so as to avoid kinks in at least one of the first wire and the second wire that can develop subsequent to the molding if a wire is not substantially straight. The tension associated with the first wire and the second wire is kept within a predetermined range or below a predetermined threshold. The predetermined range/threshold depends on a temperature associated with the injection molding. The injection molding can provide a zip structure over the wires such that the zip structure can be zipped-together and zipped-apart to prevent entanglement of the wires when used by a user. | 02-23-2012 |
20140050349 | Cable Organization Assemblies - A zipper assembly is described that includes a first set of electrical wires, a second set of electrical wires, and a first set of zipper teeth. The first set of electrical wires can be encapsulated by a first inner layer made of a thermo-resistant material. The second set of electrical wires can be encapsulated by a second inner layer made of the thermo-resistant material. The first set of zipper teeth can be connected to a zipper tape fabric that is woven with the first inner layer and the second inner layer. The first set of zipper teeth can be configured to be attached to an article of clothing. The first set of zipper teeth can be releasably attached to a second set of zipper teeth attached to the article of clothing. Related methods, systems, apparatuses, and products are also described. | 02-20-2014 |
20150016655 | Cable Organization Assemblies - An electrical wire assembly is described that has a first audio electrical wire and a second audio electrical wire. These audio electrical wires can be encapsulated by a thermo-resistant material. The thermo-resistant material encapsulating the first audio electrical wire can encapsulate a ridge, and the thermo-resistant material encapsulating the second audio electrical wire can encapsulate a groove. A slider can be configured to slide along at least a portion of lengths of the first audio electrical wire and the second audio electrical wire to releasably attach the ridge and the groove. A jack can be connected to one end of the audio electrical wires. The jack can be configured to connect to an audio producing device. Earphones or headphones can be connected to the other ends of the first audio electrical wire and the second audio electrical wire. Related methods, systems, apparatuses, and products are also described. | 01-15-2015 |
Patent application number | Description | Published |
20140133665 | METHODS AND APPARATUSES FOR REPRESENTING A SOUND FIELD IN A PHYSICAL SPACE - Methods and apparatuses for representing a sound field in a physical space are provided and described as embodied in a system that includes a sound transducer array along with a touch surface-enabled display table. The array may include a group of transducers (multiple speakers and/or microphones). The array may be configured to perform spatial processing of signals for the group of transducers so that sound rendering (in configurations where the array includes multiple speakers), or sound pick-up (in configurations where the array includes multiple microphones), may have spatial patterns (or sound projection patterns) that are focused in certain directions while reducing disturbances from other directions. | 05-15-2014 |
20140136203 | DEVICE AND SYSTEM HAVING SMART DIRECTIONAL CONFERENCING - Some implementations provide a method for identifying a speaker. The method determines position and orientation of a second device based on data from a first device that is for capturing the position and orientation of the second device. The second device includes several microphones for capturing sound. The second device has movable position and movable orientation. The method assigns an object as a representation of a known user. The object has a moveable position. The method receives a position of the object. The position of the object corresponds to a position of the known user. The method processes the captured sound to identify a sound originating from the direction of the object. The direction of the object is relative to the position and the orientation of the second device. The method identifies the sound originating from the direction of the object as belonging to the known user. | 05-15-2014 |
20140136981 | METHODS AND APPARATUSES FOR PROVIDING TANGIBLE CONTROL OF SOUND - Methods and apparatuses for providing tangible control of sound are provided and described as embodied in a system that includes a sound transducer array along with a touch surface-enabled display table. The array may include a group of transducers (multiple speakers and/or microphones) configured to perform spatial processing of signals for the group of transducers so that sound rendering (in configurations where the array includes multiple speakers), or sound pick-up (in configurations where the array includes multiple microphones), have spatial patterns (or sound projection patterns) that are focused in certain directions while reducing disturbances from other directions. Users may directly adjust parameters related to sound projection patterns by interacting with the touch surface while receiving visual feedback by exercising one or more commands on the touch surface. The commands may be adjusted according to visual feedback received from the change of the display on the touch surface. | 05-15-2014 |
20140198129 | APPARATUS AND METHOD FOR CONTROLLING AN AUGMENTED REALITY DEVICE - An apparatus, a method, and a computer program product are provided. The apparatus detects an eye gaze on a first region in a real world scene, sets a boundary that surrounds the first region, the boundary excluding at least a second region in the real world scene, performs an object recognition procedure on the first region within the boundary, and refrains from performing an object recognition procedure on the at least the second region. | 07-17-2014 |
20150049001 | ENABLING REMOTE SCREEN SHARING IN OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY WITH AUGMENTED REALITY - A method, an apparatus, and a computer program product construct an augmented view as perceived by a user of an augmented reality (AR) device having an optical see-through head mounted display (HMD) with AR, for display at a remote device. An apparatus obtains scene data corresponding to a real-world scene visible through the optical see-through HMD, and screen data of at least one of a first augmented object displayed on the optical see-through HMD, and a second augmented object displayed on the optical see-through HMD. The apparatus determines to apply at least one of a first offset to the first augmented object relative to an origin of the real-world scene, and a second offset to the second augmented object relative to the origin. The apparatus then generates augmented-view screen data for displaying the augmented view on an HMD remote from the AR device. The augmented-view screen data is based on at least one of the first offset and the second offset. | 02-19-2015 |
20150049012 | VISUAL, AUDIBLE, AND/OR HAPTIC FEEDBACK FOR OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY WITH USER INTERACTION TRACKING - A method, an apparatus, and a computer program product provide feedback to a user of an augmented reality (AR) device having an optical see-through head mounted display (HMD). The apparatus obtains a location on the HMD corresponding to a user interaction with an object displayed on the HMD. The object may be an icon on the HMD and the user interaction may be an attempt by the user to select the icon through an eye gaze or gesture. The apparatus determines whether a spatial relationship between the location of user interaction and the object satisfies a criterion, and outputs a sensory indication, e.g., visual display, sound, vibration, when the criterion is satisfied. The apparatus may be configured to output a sensory indication when user interaction is successful, e.g., the icon was selected. Alternatively, the apparatus may be configured to output a sensory indication when the user interaction fails. | 02-19-2015 |
20150049013 | AUTOMATIC CALIBRATION OF EYE TRACKING FOR OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY - An apparatus for calibrating an eye tracking system of a head mounted display displays a moving object in a scene visible through the head mounted display. The object is displayed progressively at a plurality of different points (P) at corresponding different times (T). While the object is at a first point of the plurality of different points in time, the apparatus determines whether an offset between the point P and an eye gaze point (E) satisfies a threshold. The eye-gaze point (E) corresponds to a point where a user is determined to be gazing by the eye tracking system. If the threshold is not satisfied, the apparatus performs a calibration of the eye tracking system when the object is at a second point of the plurality of different points in time. The apparatus then repeats the determining step when the object is at a third point of the plurality of different points in time. | 02-19-2015 |
20150049112 | AUTOMATIC CUSTOMIZATION OF GRAPHICAL USER INTERFACE FOR OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY WITH USER INTERACTION TRACKING - A method, an apparatus, and a computer program product render a graphical user interface (GUI) on an optical see-through head mounted display (HMD). The apparatus obtains a location on the HMD corresponding to a user interaction with a GUI object displayed on the HMD. The GUI object may be an icon on the HMD and the user interaction may be an attempt by the user to select the icon through an eye gaze or gesture. The apparatus determines whether a spatial relationship between the location of user interaction and the GUI object satisfies a criterion, and adjusts a parameter of the GUI object when the criterion is not satisfied. The parameter may be one or more of a size of the GUI object, a size of a boundary associated with the GUI object or a location of the GUI object. | 02-19-2015 |
20150049113 | VISUAL SEARCH IN REAL WORLD USING OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY WITH AUGMENTED REALITY AND USER INTERACTION TRACKING - A method, an apparatus, and a computer program product conduct online visual searches through an augmented reality (AR) device having an optical see-through head mounted display (HMD). An apparatus identifies a portion of an object in a field of view of the HMD based on user interaction with the HMD. The portion includes searchable content, such as a barcode. The user interaction may be an eye gaze or a gesture. A user interaction point in relation to the HMD screen is tracked to locate a region of the object that includes the portion and the portion is detected within the region. The apparatus captures an image of the portion. The identified portion of the object does not encompass the entirety of the object. Accordingly, the size of the image is less than the size of the object in the field of view. The apparatus transmits the image to a visual search engine. | 02-19-2015 |
20150049201 | AUTOMATIC CALIBRATION OF SCENE CAMERA FOR OPTICAL SEE-THROUGH HEAD MOUNTED DISPLAY - An apparatus for calibrating an augmented reality (AR) device having an optical see-through head mounted display (HMD) obtains eye coordinates in an eye coordinate system corresponding to a location of an eye of a user of the AR device, and obtains object coordinates in a world coordinate system corresponding to a location of a real-world object in the field of view of the AR device, as captured by a scene camera having a scene camera coordinate system. The apparatus calculates screen coordinates in a screen coordinate system corresponding to a display point on the HMD, where the calculating is based on the obtained eye coordinates and the obtained object coordinates. The apparatus calculates calibration data based on the screen coordinates, the object coordinates and a transformation from the target coordinate system to the scene camera coordinate system. The apparatus then derives subsequent screen coordinates for the display of AR in relation to other real-world object points based on the calibration data. | 02-19-2015 |
Patent application number | Description | Published |
20140179303 | VARYING NEIGHBOR CELL MEASUREMENT PERIODS BASED ON SERVING CELL SIGNAL STRENGTH - A method of wireless communication enables an inter-radio access technology (IRAT) neighbor cell measurement when a serving RAT signal strength is continuously below a first threshold value for a first length of time. The method also disables the IRAT neighbor cell measurement when the serving RAT signal strength is continuously above a second threshold value for a second length of time. | 06-26-2014 |
20140355572 | METHOD AND APPARATUS FOR AUTOMATIC GAIN CONTROL FOR TD-SCDMA SYSTEMS - A method and apparatus in wireless communications is provided. The method may include measuring received powers levels for a first window of samples, and computing a gain value based on the measured received powers levels. The method may also include determining an offset duration such that the first window of samples and a second window of samples both are included within a downlink region that has downlink power within a threshold level. The method may additionally include applying the gain value to the second window of samples, and the second window of samples may occur after the offset duration. | 12-04-2014 |
20140362744 | METHOD AND APPARATUS FOR TRANSMISSION BY TIME DIVISION DUPLEXING (TDD) DEVICES USING MULTIPLE ANTENNAS - TDD devices may transmit using multiple antennas. First and second antennas having first and second receive conditions may receive a communication. In an aspect, first and second transmit conditions for the first and second antennas may be determined based on the first and second receive conditions. In an aspect, the first and second transmit conditions may be compared to select the first or second antenna for transmissions. In an aspect, the first and second receive conditions may be compared to select the first or second antenna for transmissions. In an aspect, first and second transmission conditioning values, which may determine transmission powers, may be determined based on the first and second receive conditions. A first transmission chain, associated with an active RAT or carrier, and a second transmission chain, associated with an inactive RAT or carrier, may be activated to send transmissions from the first and second antennas. | 12-11-2014 |
Patent application number | Description | Published |
20080298469 | BITRATE REDUCTION TECHNIQUES FOR IMAGE TRANSCODING - This disclosure describes techniques for encoding data to compress image data to a reduced size. The techniques may be particularly effective in transcoding an image to a reduced size for transmission. An encoding device may transcode an image to an acceptable file size using bitrate control techniques that affect the entire image uniformly to transcode the image. For example, the encoding device may modify one or more quantization tables as a function of the near linear relationship between bitrate (R) and the number of zero-valued quantized transform coefficients to reduce the file size uniformly over the entire image. Alternatively, or additionally, the encoding device may transcode the image using bitrate control techniques that affect only specific localized regions of the image. | 12-04-2008 |
20090202158 | ROTATIONAL TRANSCODING FOR JPEG OR OTHER CODING STANDARDS - This disclosure describes techniques for rotating an encoded image, such as an image encoded according to a JPEG standard. In one example, a method for rotating an encoded image comprising reordering minimum coded units (MCUs) of the encoded image according to a specified rotation of the encoded image, rotating image data within the MCUs according to the specified rotation, and generating a rotated version of the encoded image comprising the reordered MCUs and the rotated image data within the MCUs. | 08-13-2009 |
20100235421 | FAST DCT ALGORITHM FOR DSP WITH VLIW ARCHITECTURE - A single stage computation method to perform a discrete cosine transform operation is provided. The discrete cosine transform operation is performed by executing a plurality of very large instruction words (VLIW) using a digital signal processor. The plurality of very large instruction words includes a first number of multiplications and a second number of additions, where the first number of multiplications is greater than the second number of additions. | 09-16-2010 |
20100254617 | APPARATUS AND METHOD TO ROTATE AN IMAGE - Image processing systems and methods are disclosed. In a particular embodiment, a method is disclosed that includes receiving image data of an image. The image data includes a plurality of image blocks. The method further includes calculating a first differential DC value during a rotation operation of the image by comparing a first DC coefficient value of a first block of a first row of the image to a second DC coefficient value of a first block of a second row of the image. The method further includes storing the first differential DC value in a memory prior to completing the rotation operation. | 10-07-2010 |
20130201359 | METHOD AND APPARATUS FOR UNATTENDED IMAGE CAPTURE - Described is a method and apparatus for unattended image capture that can identify subjects or faces within an image captured with an image sensor. The methods and apparatus may then score the image based, at least in part, on scores of detected subjects or faces in the image, scores of facial expressions, a focus score, exposure score, stability score, or audio score. If the score of the image is above a threshold, a snapshot image may be stored to a data store on the imaging device. If the score of the image is below a threshold, one or more audible prompts may be generated indicating that subjects should change positions, smile or remain more still during the image capture process. | 08-08-2013 |
20150062434 | SYSTEMS, DEVICES AND METHODS FOR DISPLAYING PICTURES IN A PICTURE - Systems, devices, and methods of displaying and/or recording multiple pictures in a picture (PIP) on the same display of a digital display device are disclosed. The PIPs can show objects from the main field view of the display device, such as a front camera lens, as well as objects from a different field of view, such as a back camera lens. The PIPs can further track the objects that are being displayed. | 03-05-2015 |
20150063632 | SYSTEMS, DEVICES AND METHODS FOR TRACKING OBJECTS ON A DISPLAY - Systems, devices and methods for improved tracking with an electronic device are disclosed. The disclosures employ advanced exposure compensation and/or stabilization techniques. The tracking features may therefore be used in an electronic device to improve tracking performance under dramatically changing lighting conditions and/or when exposed to destabilizing influences, such as jitter. Historical data related to the lighting conditions and/or to the movement of a region of interest containing the tracked object are advantageously employed to improve the tracking system under such conditions. | 03-05-2015 |
Patent application number | Description | Published |
20080261829 | ANTIBODY-BASED ARRAYS FOR DETECTING MULTIPLE SIGNAL TRANSDUCERS IN RARE CIRCULATING CELLS - The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies. | 10-23-2008 |
20100167945 | DRUG SELECTION FOR BREAST CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. | 07-01-2010 |
20110071042 | BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY - The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. | 03-24-2011 |
20110281748 | DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer. | 11-17-2011 |
20120270745 | DRUG SELECTION FOR CANCER THERAPY BY PROFILING SIGNAL TRANSDUCTION PROTEINS IN ASCITES OR PLEURAL EFFLUX SAMPLES - The present invention provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a gastric cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from an ascites sample. The present invention also provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a lung cancer such as a non-small cell lung cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from a pleural efflux sample. | 10-25-2012 |
20120277109 | PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS - The present invention provides antibody-based arrays for detecting the activation state and/or total amount of one or a plurality of oncogenic fusion proteins in a biological sample such as whole blood or tumor tissue and methods of use thereof. In certain instances, the activation state and/or total amount of oncogenic fusion protein(s) present in a sample can be measured in combination with one or a plurality of signal transduction molecules. The compositions and methods of the present invention have the advantages of specificity associated with enzyme-linked immunosorbent assays, sensitivity associated with signal amplification, and high-throughput multiplexing associated with microarrays. | 11-01-2012 |
20130012407 | METHODS FOR PREDICTING RESPONSE OF TRIPLE-NEGATIVE BREAST CANCER TO THERAPY - The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. | 01-10-2013 |
20130045880 | DRUG SELECTION FOR BREAST CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. | 02-21-2013 |
20130237436 | DRUG SELECTION FOR GASTRIC CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer. | 09-12-2013 |
20130323711 | APPARATUS AND METHOD FOR ISOLATING LEUKOCYTES AND TUMOR CELLS BY FILTRATION - The present invention provides novel apparatuses and methods for isolating or recovering a subset of blood cells such as leukocytes and/or circulating tumor cells from blood samples by filtration without changing the intracellular concentration of a therapeutic agent such as an anticancer drug. Contrary to the art, the apparatuses and methods of the present invention advantageously provide cell lysates from recovered cells such as leukocytes and/or circulating tumor cells without substantial dilution of a therapeutic agent such as an anticancer drug. | 12-05-2013 |
20140024548 | DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides methods for selecting a suitable anticancer drug therapy, and for identifying and predicting response, for the treatment of a malignant cancer involving aberrant c-Met signaling. The present invention also provides methods for monitoring the status of a malignant cancer involving aberrant cMet signaling and monitoring how a patient with the malignant cancer is responding to anticancer drug therapy. | 01-23-2014 |
20140187445 | ANTIBODY-BASED ARRAYS FOR DETECTING MULTIPLE SIGNAL TRANSDUCERS IN RARE CIRCULATING CELLS - The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies. | 07-03-2014 |
20140273006 | METHOD OF THERAPY SELECTION FOR PATIENTS WITH CANCER - The present invention provides methods for detecting, measuring and quantitating the expression and activation states of signal transduction analytes in cells such as tumor cells. The invention also provides methods for selecting therapy, optimizing therapy, monitoring therapeutic efficacy, and/or detecting therapeutic resistance. Accordingly, the methods are useful for improving cancer therapy selection and disease monitoring. | 09-18-2014 |
20140349865 | DRUG SELECTION FOR BREAST CANCER THERAPY USING ANTIBODY-BASED ARRAYS - The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. | 11-27-2014 |
20150051107 | ANTIBODY-BASED ARRAYS FOR DETECTING MULTIPLE SIGNAL TRANSDUCERS IN RARE CIRCULATING CELLS - The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies. | 02-19-2015 |
Patent application number | Description | Published |
20110070185 | IDENTIFICATION OF ANTIGENIC PEPTIDES FROM MULTIPLE MYELOMA CELLS - Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines. | 03-24-2011 |
20120045466 | IDENTIFICATION OF ANTIGENIC PEPTIDES FROM MULTIPLE MYELOMA CELLS - Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines. | 02-23-2012 |
20120045829 | IDENTIFICATION OF ANTIGENIC PEPTIDES FROM MULTIPLE MYELOMA CELLS - Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines. | 02-23-2012 |
20120046645 | IDENTIFICATION OF ANTIGENIC PEPTIDES FROM MULTIPLE MYELOMA CELLS - Multiple myeloma (MM) is a clonal B cell malignancy and remains essentially incurable by conventional anti-tumor therapy. Patients with MM have a median survival of only three years. MM is characterized by proliferation and accumulation of mature plasma cells in the bone marrow (BM) leading to bone destruction, BM failure, anemia, and reduced immune function. The identification of MHC Class I, HLA-A2, associated peptides presented on multiple myeloma cells is an important step in developing immunotherapies for MM. Presented here are methods for creating activated T lymphocytes that are cytotoxic to both peptide loaded T2 target cells and multiple myeloma cell lines. | 02-23-2012 |
Patent application number | Description | Published |
20080207635 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders - The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use. | 08-28-2008 |
20100144798 | Modulators of ATP-Binding Cassette Transporters - The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. | 06-10-2010 |
20110003790 | PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS - The invention provides a class of compounds of Formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT3, c-Kit, RET, TrkA, TrkB, TrkC, IGR-IR, AIk, c-FMS, or combinations thereof. | 01-06-2011 |
20110003798 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat o prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT*, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS or combinations thereof. | 01-06-2011 |
20110053897 | COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity. | 03-03-2011 |
20120184526 | COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein are a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity. | 07-19-2012 |
20120184583 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS - The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. | 07-19-2012 |
20130053376 | NOVEL TYROSINE KINASE INHIBITORS - Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use. | 02-28-2013 |
Patent application number | Description | Published |
20110081053 | METHODS AND SYSTEMS FOR OCCLUSION TOLERANT FACE RECOGNITION - Certain embodiments of the present disclosure relate to a method for face recognition that is occlusion tolerant and scale/shift invariant based on a combination of hierarchical maximization and adaptive representation technique. | 04-07-2011 |
20110188757 | IMAGE RECOGNITION SYSTEM BASED ON CASCADED OVER-COMPLETE DICTIONARIES - Certain embodiments of the present disclosure relate to a technique for image reconstruction that employs cascaded over-complete dictionaries (i.e., collections of bases) for extracting features and building representations for images at different reconstruction levels. Each dictionary on a different reconstruction level can be learned and optimized for the purpose of capturing either generic or discriminative features. By finding sparse representations through the cascaded dictionaries, an image can be reconstructed and recognized. | 08-04-2011 |
20140049487 | INTERACTIVE USER INTERFACE FOR CLOTHING DISPLAYS - Techniques are disclosed for providing a user interface on a flexible display integrated on and/or into clothing. All or a portion of an article of clothing can function as a flexible display, enabling a user interface to be provided to a wearer of the article of clothing in a customized manner. The customized manner can be based on the type of information provided in the user interface and/or a triggering event invoking the user interface. | 02-20-2014 |
20150052093 | METHODS AND APPARATUS FOR MODULATING THE TRAINING OF A NEURAL DEVICE - Methods and apparatus are provided for training a neural device having an artificial nervous system by modulating at least one training parameter during the training. One example method for training a neural device having an artificial nervous system generally includes observing the neural device in a training environment and modulating at least one training parameter based at least in part on the observing. For example, the training apparatus described herein may modify the neural device's internal learning mechanisms (e.g., spike rate, learning rate, neuromodulators, sensor sensitivity, etc.) and/or the training environment's stimuli (e.g., move a flame closer to the device, make the scene darker, etc.). In this manner, the speed with which the neural device is trained (i.e., the training rate) may be significantly increased compared to conventional neural device training systems. | 02-19-2015 |
Patent application number | Description | Published |
20120316240 | METHOD OF DIAGNOSIS - Disclosed herein are methods that generally to the fields of pharmaceutical chemistry, biochemistry, molecular biology and medicine. More particularly, aspects of the invention concern methods to identify a predisposition for fibrosis in a biological sample, methods of identifying agents that modulate the onset of fibrosis, methods of making a formulation that inhibits the onset or progression of fibrosis, and methods of monitoring the progression of fibrosis or the efficacy of a fibrosis treatment. | 12-13-2012 |
20130071467 | RETINOID-LIPOSOMES FOR TREATING FIBROSIS - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH1_2 (SEQ ID NOS: 60 and 127), SERPINH1_45a (SEQ ID NOS: 98 and 165), and SERPINH1_51 (SEQ ID NOS: 101 and 168), and drug carrier comprising a mixture of a retinoid and a lipid vesicle, and methods of using these pharmaceutical compositions to treat a disease associated with hsp47 expression, including fibrosis. | 03-21-2013 |
20130071478 | RETINOID-LIPOSOMES FOR ENHANCING MODULATION OF HSP47 EXPRESSION - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH | 03-21-2013 |
20140356413 | RETINOID-LIPOSOMES FOR TREATING FIBROSIS - What is described are pharmaceutical compositions comprising a double-stranded nucleic acid molecule comprising a sense strand and an antisense strand wherein the sense and antisense strands are selected from the oligonucleotides described as SERPINH1_2 (SEQ ID NOS: 60 and 127), SERPINH1_45a (SEQ ID NOS: 98 and 165), and SERPINH1_51 (SEQ ID NOS: 101 and 168), and drug carrier comprising a mixture of a retinoid and a lipid vesicle, and methods of using these pharmaceutical compositions to treat a disease associated with hsp47 espresssion, including fibrosis. | 12-04-2014 |
Patent application number | Description | Published |
20100086918 | Methods for High Sensitivity Detection of Genetic Polymorphisms - Multiplex PCR-based methods for detecting a variant polynucleotide having a nucleotide sequence differing from the wild-type nucleotide sequence of a nucleic acid molecule, wherein the variant polynucleotide is in a sample containing an excess of the wild-type nucleic acid molecule. The methods are particularly useful for detection of deletions from, or translocations and inversions in, genomic DNA. The susceptibility to, diagnosis of, and progression of a disease clinically related to the occurrence of such polymorphisms in an individual may also be confirmed and monitored using the multiplex PCR-based methods or by detecting RNA fusion transcripts in a sample that correspond to previously identified deletions, translocations or inversions in genomic DNA. | 04-08-2010 |
20140288398 | COMPOSITIONS AND DEVICES FOR THE DETECTION OF BIOMARKERS IN THE GASTROINTESTINAL TRACT AND METHODS FOR MAKING AND USING THEM - In alternative embodiments, the invention provides compositions such as devices, pills, beads, capsules, products of manufacture, particles, microparticles, nanoparticles, gels, liquid gels, liquid gel capsules, capsules, tablets, geltabs, liquids, sprays, emulsions, suspensions, pastes or yogurts, for the detection and isolation of biomarkers, nucleic acids, proteins or peptides, proteoglycans, lipids, fats, sugars or polysaccharides in the gastrointestinal tract for e.g., detecting the presence of particular exogenous or endogenous nucleic acids, e.g., DNA or RNA, or proteins, in the gastrointestinal tract, for example, to diagnose the presence of an infectious or exogenous agent such as a virus, a fungus, a parasite, a bacteria, intestinal helminths and protozoan parasites, and the like, or a biomarker such as a cancer-causing or cancer-predisposing allele, e.g., mutations of the KRAS2 oncogene in pancreatic cancer. In alternative embodiments, compositions of the invention comprise magnetic particles such as a magnetically-responsive microparticle or nanoparticle; a superparamagnetic bead or polystyrene bead; a superparamagnetic fine particle; a ferrimagnetic particle; or, a magnetic microsphere, nanosphere, microbead or nanobeads. In alternative embodiments, the invention provides methods for detecting, retrieving, capturing or isolating a sample of a nucleic acid, or an anionic, cationic or hydrophobic protein or peptide, a mucin, a phosphoprotein, a proteoglycan or a polysaccharide, in vivo. | 09-25-2014 |
Patent application number | Description | Published |
20120069344 | HIGH RESOLUTION STRUCTURED ILLUMINATION MICROSCOPY - Disclosed are systems, apparatus, methods and devices, including a method that includes generating two or more sequential surface plasmon interference patterns, at least one of the two or more sequential surface plasmon interference patterns being different from another of the two or more sequential surface plasmon interference patterns, and capturing respective images of a specimen resulting from the interference patterns. Also disclosed is a method that includes generating two or more sequential optical interference patterns, at least one of the two or more sequential optical interference patterns being different from another of the interference patterns, and removing from each of the generated interference patterns, using a beam stopper, a corresponding zero-order diffraction light component included in the respective generated patterns to obtain resultant corresponding two or more sequential optical interference patterns, directed at a specimen, with missing respective zero-order light components. | 03-22-2012 |
20120229891 | PLASMONIC DARK FIELD AND FLUORESCENCE MICROSCOPY - Plasmonic condensers for generating surface plasmon at an evanescent wave surface can include a substrate layer, a metal layer comprising the evanescent wave surface; and a media layer disposed between the metal layer and the substrate layer. The media layer can be active or passive and can include a source of radiation that interacts with the metal layer to create surface plasmons that are not substantially optically detectable as far field radiation until an interfering object is brought into proximity with the evanescent wave surface. When an interfering object such as a sample or specimen is brought into proximity with the evanescent wave surface, it causes coupling of at least some of the surface plasmons into propagating radiation detectable by an objective lens. Systems, methods, and the like are disclosed, as are features of a plasmonic meta-materials illuminator. | 09-13-2012 |
20120328240 | METAMATERIAL-BASED OPTICAL LENSES - Devices based on metamaterial structures to guide and manipulate light, other electromagnetic radiation and acoustic waves. For example, a lens can include a metamaterial structure comprising nano structures of metallic and dielectric materials; and a plasmonic waveguide coupler formed over the metamaterial structure for coupling electromagnetic radiation to or from metamaterial structure. The metamaterial structure has an anisotropic structure and the plasmonic waveguide coupler is structured to include metal and non-metal parts to support surface plasmon polaritons and to cause different phase delays at different locations of an interface with the metamaterial structure in a way that the metamaterial structure and the plasmonic waveguide coupler effect a lens for performing a Fourier transform of the electromagnetic radiation coupled between the metamaterial structure and the plasmonic waveguide coupler. | 12-27-2012 |
Patent application number | Description | Published |
20100050039 | HANDLING OF DISRUPTED SYNCHRONOUS HYBRID AUTOMATIC REPEAT REQUEST (HARQ) CYCLE AT SYSTEM TIME ROLLOVER - Certain aspects of the present disclosure propose techniques for avoiding a disruption in synchronous hybrid automatic repeat request operation at system time rollover. The techniques define the behavior of a system before and after the system frame number (SFN) rollover point to ensure a known relationship between a hybrid automatic repeat request (HARQ) process identification number and system time. | 02-25-2010 |
20110292823 | SOUNDING REFERENCE SIGNAL (SRS) IN HETEROGENEOUS NETWORK (HETNET) WITH TIME DIVISION MULTIPLEXING (TDM) PARTITIONING - Methods and apparatus for uplink (UL) radio link monitoring (RLM) in a Long Term Evolution (LTE) heterogeneous network (HetNet) with enhanced inter-cell interference coordination (eICIC) are described. Various options are presented in an effort to transmit a sounding reference signal (SRS) of a user equipment device (UE) served by a Node B in the HetNet, avoiding both interference from UL transmissions from other UEs being served by neighboring Node Bs and collisions with the UE's own channel quality information (CQI) or physical uplink shared channel (PUSCH), for example. | 12-01-2011 |
20110292917 | SYSTEM AND METHOD FOR TIMING ADJUSTMENT TO PROTECT CQI - Certain aspects of the present disclosure propose methods for protecting channel quality indicator (CQI) modulation symbols in a subframe (e.g., a localized frequency division multiplexing (LFDM) subframe). For some aspects, a timing adjustment method may be utilized to adjust time of a UE with respect to an eNodeB. The timing adjustment method may introduce a positive time offset to be used for reducing time mismatch between the UE and the eNodeB. In another aspect, a buffer may be used at the eNodeB to store symbols received by the eNodeB before removing the cyclic prefix information from the subframe. The eNodeB may use the stored symbols and an artificial time delay to ensure that the CQI information is protected. For some aspects, the CQI modulation symbols may not be located at the beginning of an LFDM symbol. | 12-01-2011 |
20120106439 | CELL SITE MODEM APPLICATION MESSAGE INTERFACE - Certain aspects of the present disclosure relate to a technique for implementing a cell site modem application message interface (CSM API) for a cell site of Long Term Evolution (LTE) wireless system. | 05-03-2012 |
20120184314 | DETERMINING AN UPLINK CONTROL PATH WITH BLIND DECODING - In an aspect, a method assists with blind decoding of uplink control signals on a Physical Uplink Shared Channel (PUSCH) and Physical Uplink Control Channel (PUCCH). The method assists in determining the uplink control path in the event a user equipment (UE) misses an uplink grant and blind decoding occurs. It is determined whether an uplink acknowledgement, rank indicator, and/or channel quality indicator are found on a PUSCH. If not, it is determined whether a scheduling request is expected and whether special handling for the scheduling request is indicated. Depending on those determinations, and whether any decoding attempts for uplink signals are successful, either the PUSCH or PUCCH is selected as the uplink control path. | 07-19-2012 |
20120202493 | METHOD AND APPARATUS FOR COUNTING DEVICES RELATED TO BROADCAST DATA SERVICES - Methods and apparatuses are provided that include counting devices for broadcast data services. The devices can be counted based on registrations received from the devices. This registration count can additionally or alternatively be used to determine whether further counting is desired. In addition, base stations can transmit counting requests to the devices using a paging message or other message such that idle mode devices can receive the counting requests. The idle mode devices can respond to the requests or send autonomous counting report by switching to an active mode for the purpose of responding or another purpose. | 08-09-2012 |
20120213130 | CARRIER AGGREGATION FOR EVOLVED MULTIMEDIA BROADCAST MULTICAST SERVICE ENHANCEMENT - Carrier aggregation to enhance Evolved Multimedia Broadcast Multicast Service (eMBMS) includes transmitting unicast signaling for a unicast service on an anchor carrier to mobile entities, transmitting eMBMS signaling on a second carrier different from the anchor carrier to the mobile entities for use with the unicast signaling, and various techniques for practical application of carrier aggregation for eMBMS enhancement. In addition, allocating subframes used for MBMS on a Single Frequency Network (MBSFN) includes allocating at least a portion of one or more subframes otherwise reserved for unicast subframes on a mixed carrier to provide an increased allocation of subframes carrying MBSFN information, transmitting MBSFN signals on the increased allocation of subframes, and more detailed aspects. | 08-23-2012 |
20120236776 | TARGET CELL SELECTION FOR MULTIMEDIA BROADCAST MULTICAST SERVICE CONTINUITY - Transfer of Multimedia Broadcast/Multicast Services (MBMS) over a Single Frequency Network (MBSFN) service and idle mode unicast service for a mobile entity from a source base station to a target base station may be managed by a base station or mobile entity of a cellular wireless communications system (WCS). Operations related to the transfer may include obtaining an MBMS status of the mobile entity, and/or obtaining MBMS support information for the base station. A network entity may facilitate MBMS discovery by a mobile entity, by transmitting a data element to the mobile entity including service identifiers mapped to corresponding cell identifiers to indicate respective MBMS services to be broadcast in an WCS area on adjacent cells identified by respective ones of the cell identifiers. The MBMS services may be broadcast within the WCS area using the adjacent cells previously indicated in the data element. | 09-20-2012 |
20120275399 | SYSTEM AND METHOD FOR SYNCHRONIZED RADIO LINK CONTROL AND MEDIA ACCESS CONTROL IN A WIRELESS COMMUNICATION NETWORK - Techniques are provided for synchronized radio link control (RLC) and/or media access control (MAC). For example, there is provided a method that involves generating an RLC protocol data unit (PDU) according to a segmentation protocol for maximizing RLC PDU size while allowing the RLC PDU to fit into a defined MAC transport block, the RLC PDU comprising at least one RLC service data unit (SDU) or RLC SDU segment. The method may involve determining a PDU data size for each given RLC SDU. The method may further involve (a) attaching a given RLC SDU to the RLC PDU and (b) delivering the RLC PDU to a lower layer, in response to a SDU data size for the given RLC SDU exceeding a defined size limit. | 11-01-2012 |
20120314591 | TRACKING LOOP DESIGN FOR UNICAST AND MULTICAST/BROADCAST SIGNALS - A method, an apparatus, and a computer program product for wireless communication are provided. In a first configuration, the apparatus maintains a first set of tracking loops associated with unicast signals and a second set of tracking loops associated with multicast/broadcast signals. In addition, the apparatus decoding at least one of a received unicast signal based on the first set of tracking loops or a received multicast/broadcast signal based on the second set of tracking loops. In a second configuration, the apparatus maintains a TTL and a FTL associated with unicast signals based only on received unicast signals. In addition, the apparatus receives a multicast/broadcast signal and decodes the received multicast/broadcast signal based on the TTL and the FTL maintained based only on the received unicast signals. | 12-13-2012 |
20130039292 | MITIGATION OF LOST RESOURCE ALLOCATION SYNCHRONIZATION BETWEEN A USER EQUIPMENT (UE) AND AN EVOLVED NODE B (eNodeB) - A method for mitigation of lost resource allocation synchronization between a user equipment (UE) and an evolved Node B (eNodeB) during a Hybrid Automatic Repeat Request (HARQ) transmission and/or retransmission process is described. The method includes determining whether resource allocation is out of synchronization between a user equipment (UE) and an evolved Node B (eNodeB) during a hybrid automatic repeat request (HARQ) transmission and/or retransmission process. The method further includes mitigating a loss of resource allocation synchronization between the UE and the eNodeB during the HARQ transmission and/or retransmission process. | 02-14-2013 |
20130114492 | METHOD AND APPARATUS FOR MITIGATING CONTROL CHANNEL ERROR - Methods and apparatuses are provided that include decoding multicast broadcast communications where scheduling information related to a multicast channel is not properly received over a control channel. Media access control (MAC) packets can be decoded to determine whether a MAC subheader indicates the packet relates to a logical channel by indicating an associated channel identifier. Where the channel identifier of the MAC packet matches that of a requested logical channel, data in the MAC packet can be provided to a communications layer. Subsequent packets can be processed and provided to the communications layer until a different channel identifier is encountered. | 05-09-2013 |
20130128768 | METHOD AND APPARATUS FOR ENHANCING CONTROL CHANNEL TRANSMISSION - Methods and apparatuses are provided that include enhancing decoding of multicast broadcast control communications, which can be of a relatively large size. A configuration message related to a broadcast channel structure can be received in multiple instances and/or segmented data units. A receiver can combine multiple instances and/or accumulate segmented data units to obtain and/or decode a control channel over which the configuration message is communicated. Communicating segmented data units of the configuration message can allow a broadcast station to utilize a lower data rate, more reliable modulation and coding scheme to encode the configuration message. | 05-23-2013 |
20130272185 | METHOD AND APPARATUS FOR ENHANCING CONTROL CHANNEL TRANSMISSION - Methods and apparatuses are provided that include enhancing decoding of multicast broadcast control communications, which can be of a relatively large size. A configuration message related to a broadcast channel structure can be received in multiple instances and/or segmented data units. A receiver can combine multiple instances and/or accumulate segmented data units to obtain and/or decode a control channel over which the configuration message is communicated. Communicating segmented data units of the configuration message can allow a broadcast station to utilize a lower data rate, more reliable modulation and coding scheme to encode the configuration message. | 10-17-2013 |
20140241149 | SYSTEMS AND METHODS FOR SYNCHRONIZING WIRELESS COMMUNICATION DEVICE CONFIGURATIONS - An apparatus operable in a communication system is described. The apparatus includes means for sending a connection reconfiguration message using a first configuration. The apparatus also includes means for receiving an acknowledgement message using the first configuration. The apparatus also includes means for applying a second configuration as indicated in the acknowledgement message. The apparatus also includes means for sending a connection reconfiguration complete message uplink grant in a common search space. The apparatus also includes means for receiving a connection reconfiguration complete message using the second configuration. | 08-28-2014 |
Patent application number | Description | Published |
20100029605 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-R, b-Raf, c-Raf, SAPK2, Src, Tie2 and TrkB kinases. | 02-04-2010 |
20100081656 | COMPOSITIONS AND METHODS FOR MODULATING C-KIT AND PDGFR RECEPTORS - The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit, PDGFRα, PDGFRβ, CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGFβ, SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2β, BRK, KDR, c-raf or b-raf kinase, or mutant forms thereof. | 04-01-2010 |
20100168182 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly TrkA, TrkB, TrkC, PDGFR and c-kit. | 07-01-2010 |
20100184765 | Protein Kinase Inhibitors and Methods for Using Thereof - The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of Alk, Abl, Aurora-A, B-Raf, C-Raf, Bcr-Abl, BRK, Blk, Bmx, BTK, C-Kit, CSK, C-Src, EphB1, EphB2, EphB4, FLT1, Fms, Flt3, Fyn, FRK3, JAK2, KDR, Lck, Lyn, PDGFRα, PDGFRβ, PKCα, SAPK2α, Src, SIK, Syk, Tie2 and TrkB kinases. | 07-22-2010 |
20110052578 | Compounds and Compositions as Protein Kinase Inhibitors - The present invention provides compounds of Formula I or II: | 03-03-2011 |
20110306625 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. | 12-15-2011 |
20130143899 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds of Formula (I) (wherein A, Y, R | 06-06-2013 |
20130296318 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf. | 11-07-2013 |
20140011825 | Compounds and Compositions as Protein Kinase Inhibitors - The present invention provides compounds of Formula I or II: | 01-09-2014 |